These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12002913)

  • 1. The activation of platelet aggregation by human cholangiocarcinoma cells is mediated through thrombin receptor.
    Akarasereenont P; Chotewuttakorn S; Aiamsa-Ard T; Thaworn A
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S710-21. PubMed ID: 12002913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling pathways for induction of platelet aggregation by SAS tongue cancer cells--a mechanism of hematogenous metastasis.
    Chang MC; Chan CP; Ho YS; Lee JJ; Lin PS; Lin BR; Huang YL; Hahn LJ; Yeh HW; Wang YJ; Jeng JH
    J Oral Pathol Med; 2009 May; 38(5):434-40. PubMed ID: 18811671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
    Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
    Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of SNARE proteins in thrombin-induced platelet aggregation: evidence for the relevance of Ca2+ entry.
    Jardin I; Ben Amor N; Hernández-Cruz JM; Salido GM; Rosado JA
    Arch Biochem Biophys; 2007 Sep; 465(1):16-25. PubMed ID: 17543880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.
    Lempinen M; Isoniemi H; Mäkisalo H; Nordin A; Halme L; Arola J; Höckerstedt K; Stenman UH
    J Hepatol; 2007 Nov; 47(5):677-83. PubMed ID: 17640760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma.
    Thelen A; Scholz A; Benckert C; Weichert W; Dietz E; Wiedenmann B; Neuhaus P; Jonas S
    Ann Surg Oncol; 2008 Mar; 15(3):791-9. PubMed ID: 18172731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-aggregating activities of metastasizing tumor cells. III. Platelet aggregation as resulting from thrombin generation by tumor cells.
    Tohgo A; Tanaka NG; Ogawa H
    Invasion Metastasis; 1985; 5(2):96-105. PubMed ID: 3980164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines.
    Heinmöller E; Schropp T; Kisker O; Simon B; Seitz R; Weinel RJ
    Scand J Gastroenterol; 1995 Oct; 30(10):1008-16. PubMed ID: 8545606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation-induced by caco-2 cells: regulation by matrix metalloproteinase-2 and adenosine diphosphate.
    Medina C; Jurasz P; Santos-Martinez MJ; Jeong SS; Mitsky T; Chen R; Radomski MW
    J Pharmacol Exp Ther; 2006 May; 317(2):739-45. PubMed ID: 16424148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
    Wu CC; Teng CM
    Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Procoagulant and aggregating platelet activities of human mammary tumor cells].
    Jung G; Millon-Collard R; Abecassis J
    Bull Cancer; 1991; 78(3):253-60. PubMed ID: 2054524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.
    Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Wongkham S
    Cancer; 2007 Jun; 109(12):2497-505. PubMed ID: 17487855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus and intrahepatic cholangiocarcinoma.
    Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN
    Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target.
    Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S
    Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.
    Derian CK; Damiano BP; Addo MF; Darrow AL; D'Andrea MR; Nedelman M; Zhang HC; Maryanoff BE; Andrade-Gordon P
    J Pharmacol Exp Ther; 2003 Feb; 304(2):855-61. PubMed ID: 12538843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
    Lin ZY; Chuang WL; Chuang YH; Yu ML; Hsieh MY; Wang LY; Tsai JF
    J Gastroenterol Hepatol; 2006 Feb; 21(2):398-405. PubMed ID: 16509865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro.
    Kasuda S; Sakurai Y; Shima M; Morimura Y; Kudo R; Takeda T; Ishitani A; Yoshioka A; Hatake K
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1608-14. PubMed ID: 16930224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome.
    Covic L; Singh C; Smith H; Kuliopulos A
    Thromb Haemost; 2002 Apr; 87(4):722-7. PubMed ID: 12008957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.